Mary Amanda Dew, PhD
- 4Articles
- 9.3KReads1
- 1999–2009Active
- 20Collaborators
- 95Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Mary Amanda Dew, PhD, has published extensively on the treatment of depression and anxiety in late-life populations, with a focus on pharmacological interventions such as aripiprazole, citalopram, and paroxetine. Her work addresses clinical challenges in managing major depressive disorder, insomnia, and treatment-resistant cases among older adults. Dew’s research, appearing between 1999 and 2009, contributes to the fields of psychiatry and neurology, often collaborating with colleagues including Charles F. Reynolds III and Benoit H. Mulsant.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
